Encompass Health Corporation (EHC)
NYSE: EHC · Real-Time Price · USD
112.50
-0.52 (-0.46%)
Dec 5, 2025, 4:00 PM EST - Market closed
Encompass Health Stock Forecast
Stock Price Forecast
According to 8 professional analysts, the 12-month price target for Encompass Health stock ranges from a low of $125 to a high of $160. The average analyst price target of $141.88 forecasts a 26.12% increase in the stock price over the next year.
Price Target: $141.88 (+26.12%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 30, 2025.
Analyst Ratings
The average analyst rating for Encompass Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Buy | 6 | 6 | 4 | 4 | 5 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 6 | 7 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $141 → $150 | Buy | Maintains | $141 → $150 | +33.33% | Oct 30, 2025 |
| UBS | UBS | Strong Buy Maintains $140 → $150 | Strong Buy | Maintains | $140 → $150 | +33.33% | Oct 2, 2025 |
| Keybanc | Keybanc | Buy Maintains $135 → $140 | Buy | Maintains | $135 → $140 | +24.44% | Sep 16, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $145 → $160 | Strong Buy | Maintains | $145 → $160 | +42.22% | Sep 10, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $135 → $140 | Strong Buy | Maintains | $135 → $140 | +24.44% | Aug 14, 2025 |
Financial Forecast
Revenue This Year
5.99B
from 5.37B
Increased by 11.54%
Revenue Next Year
6.52B
from 5.99B
Increased by 8.78%
EPS This Year
5.35
from 4.46
Increased by 20.04%
EPS Next Year
5.87
from 5.35
Increased by 9.64%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 6.3B | 6.8B | ||
| Avg | 6.0B | 6.5B | ||
| Low | 5.8B | 6.3B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 16.5% | 13.9% | ||
| Avg | 11.5% | 8.8% | ||
| Low | 8.1% | 4.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 5.62 | 6.52 | ||
| Avg | 5.35 | 5.87 | ||
| Low | 5.15 | 5.33 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 26.0% | 21.8% | ||
| Avg | 20.0% | 9.6% | ||
| Low | 15.4% | -0.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.